This puts Spark in the vanguard of gene and cell therapy, and if approved by the FDA, it will be the first ever gene therapy for a genetic disease to reach the US market.
GEMMABio says it will use the funds to develop new gene therapies for rare diseases but offered no details regarding specific ...
From reprogrammed stem cells to next-generation ... and flexible editor may help us replace these disease-causing genetic sequences entirely.” Gene Therapy Allows a Deaf Child to Hear For ...
Labcorp Watch the second of a three-part roundtable series that focus on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep ...
WBEN Radio Buffalo on MSN11d
Gov. Hochul helps celebrate opening of New York's first cell, gene therapy hub at Roswell ParkDuring a visit to Buffalo on Monday, New York Gov. Kathy Hochul joined the leaders of Roswell Park to celebrate the opening ...
The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...
Roswell Park Comprehensive Cancer Center next month will open a $98 million facility dedicated to developing new cancer ...
Roswell Park Comprehensive Cancer Center celebrated the opening of the GMP Engineering and Cell Manufacturing Facility, New ...
Exegenesis Bio, a clinical stage global gene therapy ... cells with improved efficacy, safety and dosing. The first patient has been dosed in a China clinical trial and the company plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback